German Camelot Consulting Group has developed a Blockchain-based solution for the management of sensitive medical data, Cointelegraph auf Deutsch reported Monday, April 9.
According to the company, Hypertrust X-Chain’s closed-loop distribution chain strategy prevents any confusion or abuse of data and samples during treatment.
Using its Hypertrust X-Chain data control platform, the company aims to supply the health care industry a protected electronic platform for the exchange of individual data. It aims to offer all celebrities that are licensed to take part in the treatment process with decentralized data storage based on Blockchain technology.

The major Polish bank PKO Bank Polski recently declared its intention to present an Blockchain-based storage and verification system for the management of their documents of its own customers. Since Cointelegraph reported in March, Audi is presently analyzing its own Blockchain technology for tackling physical and financial distribution processes in global logistics.

The system created by Camelot Consulting Group is merely one of an even longer record of Blockchain projects for data management. Chile’s national energy regulatory firm announced a couple of days ago that it’s going to handle national energy industry data via an Ethereum-based platform.

All data transactions are encrypted and stored in an unchangeable Blockchain and will be carried out directly between the licensed participants, the company says. Additionally, it will permit the “integration of partner methods”, “real-time temperature, place and quality management in addition to reliable proof of origin”.

Released at Tue, 10 Apr 2018 09:13:59 +0000
“Many distinct actors are involved in this process, such as the healing practice, the mobile removal center, logistics service providers and pharmaceutical businesses. Today, most important data is still sent by analog means to be able to be listed again in the span of the further process. The chance of erroneous data and data misuse is so immensely significant.”

To illustrate the benefits of this new system when compared with conventional procedures, Camelot Consulting Group utilizes the instance of extracorporeal cell treatments where patients’ cells have been processed and removed in a complex, multistage process.